Idiopathic Pulmonary Fibrosis (IPF) Treatment Market Value Chain, Factor Analysis, Region and Forecasts Till 2027
Market Highlights It is estimated that the global IPF treatment market is expected to register a CAGR of 12.3% during the forecast period of 2022 to 2027, with a market value of USD 2,237 million in 2022. IPF is a life-threatening condition of the lungs in which tissues becomes thickened, stiff, and scarred over a long period. The IPF treatment market is driven by various factors such as growing demand for minimally invasive procedures to diagnose and treat different chronic diseases, increasing geriatric population, along with the rising prevalence rates of IPF and other fibrotic diseases. However, the high cost of surgery and the unavailability of proper treatment options are expected to curb the growth of the IPF treatment market. The global idiopathic pulmonary fibrosis market is currently dominated by numerous market players. The key players are involved in new product launches and strategic collaborations to strengthen its market position. For instance, in Septe...